NNZ 2566,
NNZ-2566,
NNZ2566,
Trofinetide,
853400-76-7,
UNII-Z2ME8F52QL,
Z2ME8F52QL,
L-Glutamic acid, glycyl-2-methyl-L-prolyl-,
NNZ-2566,
Trofinetide [INN],
NNZ 2566,
CHEMBL197084,
SCHEMBL1170014,
CTK3C8925,
Gly-2-Methyl-L-Pro-L-Glu-OH,
BCP17581,
AKOS030607026,
CS-8154,
SB17243,
HY-16757,
A16972,
Trofinetide, NNZ2566 ,NNZ 2566, NNZ-2566,
H-Gly-PMe-Glu-OH,
D02QFW,
D0C9AM,
C13-H21-N3-O6,
CID11318905,
glycyl-L-2-methylprolyl-L-glutamic acid,
Glycyl-2-methyl-L-prolyl-L-glutamic acid,
NNZ-2566 (oral, neurodegeneration/injury),
Glypromate analogs (oral, neuroprotection), Neuren,
NNZ-2566 (oral, neurodegeneration/injury), Neuren,
(2S)-2-[[(2S)-1-(2-aminoacetyl)-2-methyl-pyrrolidine-2-carbonyl]amino]pentanedioic Acid,